Targeted and non-targeted metabolic time trajectory in plasma of patients after acute coronary syndrome
Authors:
- Antonia GarciaAGAntonia Garcia
- José TuñónJTJosé Tuñón
- Jose Luis Martin-VenturaJMJose Luis Martin-Ventura
- Nieves TarínNTNieves Tarín
- Lorenzo López BescósLBLorenzo López Bescós
- Jesús EgidoJEJesús Egido
- Coral BarbasCBCoral Barbas
- Francisco J. RupérezFrancisco J. Rupérez
- 1 September 2011
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 56 (2) , 343-351
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Improving Metabolite Knowledge in Stable Atherosclerosis Patients by Association and Correlation of GC-MS and1H NMR FingerprintsJournal of Proteome Research, 2009
- Plasma fingerprinting with GC-MS in acute coronary syndromeAnalytical and Bioanalytical Chemistry, 2009
- Human metabolic phenotype diversity and its association with diet and blood pressureNature, 2008
- Plasma fatty acid metabolic profile coupled with uncorrelated linear discriminant analysis to diagnose and biomarker screening of type 2 diabetes and type 2 diabetic coronary heart diseasesMetabolomics, 2007
- Proton NMR analysis of plasma is a weak predictor of coronary artery diseaseNature Medicine, 2006
- Metabolomic Identification of Novel Biomarkers of Myocardial IschemiaCirculation, 2005
- Proteomic and Metabolomic Analyses of Atherosclerotic Vessels From Apolipoprotein E-Deficient Mice Reveal Alterations in Inflammation, Oxidative Stress, and Energy MetabolismArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancersProceedings of the National Academy of Sciences, 2005
- Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertensionThe Analyst, 2002
- Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomicsNature Medicine, 2002